Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Ovarian Cancer

Clinical Trials

    • Cancer(1)
  • Phase 1 Cancers

    A Phase 1, First-in-Human Study of CUSP06, a Cadherin-6 (CDH6)-Directed Antibody-Drug Conjugate, in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

    • About Us
    • Contact Us
    • Donate
    • Referring Doctors
    • Clinical Keywords

    333 Cedar St.

    New Haven, CT 06510

    • Yale School of Medicine
    • Yale University
    • Terms & Privacy Policies
    • Accessibility at YSM
    • Patient Rights
    • HIPAA at Yale
    • Non-discrimination Statement
    Copyright 2025 Yale Medicine